Get notified when TNGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTango Therapeutics announces two director resignations alongside Q1 2026 earnings release
Filed May 13, 2026 · Period ending May 13, 2026 · ~1 min read
Key Changes
-
medium
Lead Independent Director Alexis Borisy and director Kanishka Pothula both resigned from the Board effective May 13, 2026. The company stated neither resignation resulted from disagreements on operations, practices, or policies.
Item 5.02 verify on EDGAR → -
medium
Sung Lee was appointed as the new Lead Independent Director and Compensation Committee Chairperson, filling the leadership vacuum left by Borisy's departure.
Item 5.02 verify on EDGAR → -
medium
Tango issued its Q1 2026 financial results via press release on May 13, 2026. Actual financial figures are contained in the attached press release exhibit, not in the 8-K body.
Item 2.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade TNGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify